Hepion Pharmaceuticals, Inc. (HEPA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$1.67M2015: -$13.96M2016: -$20.81M2017: -$20.65M2018: -$14.59M2019: -$7.77M2020: -$20.15M2021: -$30.40M2022: -$45.49M2023: -$48.45M2024: -$19.35M2025: -$4.16M-$4.16M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$4.16M+78.5%
2024-$19.35M+60.1%
2023-$48.45M-6.5%
2022-$45.49M-49.6%
2021-$30.40M-50.9%
2020-$20.15M-159.3%
2019-$7.77M+46.8%
2018-$14.59M+29.3%
2017-$20.65M+0.8%
2016-$20.81M-49.0%
2015-$13.96M-734.9%
2014-$1.67M